Lantern Pharma Inc.
LTRN
$3.62
-$0.18-4.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.36M | 15.90M | 19.72M | 24.01M | 28.05M |
| Total Receivables | -- | -- | -- | 97.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 873.40K | 931.00K | 601.70K | 1.14M | 1.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 225.00K | 368.00K | 500.00K | -- | 748.00K |
| Total Current Assets | 13.46M | 17.20M | 20.82M | 25.25M | 29.92M |
|
|
|||||
| Total Current Assets | 13.46M | 17.20M | 20.82M | 25.25M | 29.92M |
| Net Property, Plant & Equipment | 129.10K | 182.80K | 236.20K | 287.40K | 335.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 36.70K | 36.70K | 36.70K | 36.70K | 36.70K |
| Total Assets | 13.63M | 17.42M | 21.10M | 25.57M | 30.29M |
|
|
|||||
| Total Accounts Payable | 3.06M | 3.37M | 2.93M | 2.42M | 2.55M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.00K | 131.50K | 161.50K | 190.80K | 197.30K |
| Total Finance Division Other Current Liabilities | 886.00K | 1.38M | 1.20M | 1.73M | 855.00K |
| Total Other Current Liabilities | 886.00K | 1.38M | 1.20M | 1.73M | 855.00K |
| Total Current Liabilities | 4.04M | 4.88M | 4.29M | 4.33M | 3.60M |
|
|
|||||
| Total Current Liabilities | 4.04M | 4.88M | 4.29M | 4.33M | 3.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 13.50K | 33.40K | 52.80K | 94.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.04M | 4.90M | 4.32M | 4.38M | 3.70M |
|
|
|||||
| Common Stock & APIC | 98.62M | 97.37M | 97.21M | 97.06M | 96.77M |
| Retained Earnings | -89.07M | -84.89M | -80.56M | -76.03M | -70.15M |
| Treasury Stock & Other | 40.30K | 48.00K | 131.70K | 154.00K | -25.30K |
| Total Common Equity | 9.59M | 12.52M | 16.78M | 21.19M | 26.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.59M | 12.52M | 16.78M | 21.19M | 26.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.59M | 12.52M | 16.78M | 21.19M | 26.60M |
|
|
|||||